share_log

カイオム・バイオサイエンス:ヒト化DLK-1抗体・レンバチニブ併用に関する中国における特許査定についてのお知らせ

Chiome Bioscience: Notice regarding patent assessment in China relating to the combined use of humanized DLK-1 antibodies and lenvatinib

JPX ·  Nov 26, 2024 14:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more